Prevention & Personalised Health
Pandemics & Infectious Diseases
Medical Treatment & Drug Development
Vaccines
Bacteria & Other Microorganisms
Ph.D
United Kingdom
2012.11.18
Pneumococcal vaccination strategies for crisis-affected populations
Modelling the Pneumococcal Disease
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Olivier
LE POLAIN DE WAROUX
Institution
London School of Hygiene & Tropical Medicine
Country
United Kingdom
Nationality
Belgian
Related articles
Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Drug Delivery
Biotech- and Nanotechnology
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more
Laurence
SABATIER